Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jfarr
    Junior Member
    • Mar 2015
    • 1

    getSig and sigMatrix in CummeRbund

    New cummeRbund user here! I'm trying to extract a list of differentially expressed genes from a CuffSet, but I'm finding that the values displayed in the sigMatrix plot do not match those given to me by getSig(). For example, when comparing sampleX and sampleY in the sigMatrix, it shows 101 significant genes at alpha= 0.05. However, getSig() tells me there are 140 in the same CuffSet for the same alpha value.

    Code:
    >A <- readcufflinks(dir=system.file(“data”, package=”cummerbund”))
    >A
    CuffSet instance with:
    	 6 samples
    	 23284 genes
    	 30073 isoforms
    	 25872 TSS
    	 24748 CDS
    	 348555 promoters
    	 388080 splicing
    	 305730 relCDS
    > sigMatrix(A, level=’genes’, alpha =0.05)
    >length(getSig(A, alpha=0.05, x= ‘sampleX’, y= ‘sampleY’))
    [1] 140
    Any ideas for what could account for this discrepancy? If I make sure that sigma always equals 0.05, shouldn't I be getting the same number of significantly differentially expressed genes?

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...